Alpa Laboratories
Alpa Laboratories Share Price Chart
Alpa Laboratories last traded at ₹55.71 (2026-10-13). Over the past month the stock moved -13.4%, three months the stock moved -19.8%, year the stock moved -41.1%. Its closing range over 52 weeks is ₹51.56 – ₹91.41, with the latest close 39.1% below the high.
Closing prices up to 2026-10-13.
About Alpa Laboratories
Incorporated in 1988, Alpa Laboratories Ltd manufactures and sells Drugs and Chemicals[1]
Business Overview:[1] ALL is a WHO-GMP and ISO 9001:2000 certified company. It manufactures a wide range of Pharmaceutical Finished Dosage Forms under its own brand and for other Indian and multinational companies. The product range includes a wide variety of ethical, generic, and over-the-counter (OTC) drugs in various Finished Dosage Forms for both human and veterinary use
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Alpa Laboratories reported sales of ₹23.93 crore (+25.2%) and net profit of ₹0.98 crore (-91.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 23.93 | -3.96 | -16.55 | 0.98 | 0.47 |
| Mar 2026 | 31.40 | 3.60 | 11.46 | 1.38 | 0.66 |
| Dec 2025 | 29.05 | 1.51 | 5.20 | 1.59 | 0.76 |
| Sep 2025 | 26.26 | -2.25 | -8.57 | 0.11 | 0.05 |
| Jun 2025 | 19.11 | 0.43 | 2.25 | 11.77 | 5.59 |
| Mar 2025 | 39.92 | 0.20 | 0.50 | -2.12 | -1.01 |
| Dec 2024 | 26.15 | 0.74 | 2.83 | 8.90 | 4.23 |
| Sep 2024 | 24.94 | 3.32 | 13.31 | 7.69 | 3.65 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -23.0% | -4.2% | +69.1% | -10.9% | +5.3% | +11.1% | -21.3% | +25.2% |
| Operating profit growth | -0.9% | -69.5% | -94.3% | -18.9% | -167.8% | +104.1% | +1700.0% | -1020.9% |
| Net profit growth | +32.8% | +97.3% | -159.7% | +130.8% | -98.6% | -82.1% | – | -91.7% |
| EPS growth | +32.7% | +97.7% | -159.8% | +131.0% | -98.6% | -82.0% | – | -91.6% |
| OPM % | 13.3% | 2.8% | 0.5% | 2.3% | -8.6% | 5.2% | 11.5% | -16.6% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Alpa Laboratories reported sales of ₹106.00 crore (-5.4%) and net profit of ₹15.00 crore (-25.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 106.00 | 3.00 | 3.00 | 15.00 | 7.13 |
| Mar 2025 | 112.00 | 5.00 | 4.00 | 20.00 | 9.27 |
| Mar 2024 | 109.00 | 9.00 | 8.00 | 17.00 | 7.98 |
| Mar 2023 | 93.00 | 8.00 | 9.00 | 13.00 | 5.98 |
| Mar 2022 | 112.00 | 11.00 | 10.00 | 14.00 | 6.70 |
| Mar 2021 | 97.00 | 8.00 | 8.00 | 7.00 | 3.45 |
| Mar 2020 | 85.00 | 6.00 | 7.00 | 2.00 | 0.88 |
| Mar 2019 | 77.00 | 1.00 | 1.00 | 1.00 | 0.48 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +24.2% | +10.4% | +14.1% | +15.5% | -17.0% | +17.2% | +2.8% | -5.4% |
| Operating profit growth | -75.0% | +500.0% | +33.3% | +37.5% | -27.3% | +12.5% | -44.4% | -40.0% |
| Net profit growth | -66.7% | +100.0% | +250.0% | +100.0% | -7.1% | +30.8% | +17.6% | -25.0% |
| EPS growth | -64.2% | +83.3% | +292.0% | +94.2% | -10.7% | +33.4% | +16.2% | -23.1% |
| OPM % | 1.0% | 7.0% | 8.0% | 10.0% | 9.0% | 8.0% | 4.0% | 3.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Alpa Laboratories.
Get Free AI Stock Analysis FREE →Latest News
-
Alpa Laboratories appoints Radhika Biyani as independent director - scanx.trade
-
Alpa Laboratories approves in principle to explore Nigeria incorporation - scanx.trade
-
Alpa Laboratories approves in principle to explore Nigeria incorporation - scanx.trade
-
Alpa Laboratories approves in principle to explore Nigeria incorporation - scanx.trade
-
Jyoti Jain ceases as Independent Director at Alpa Laboratories - scanx.trade
-
Pilots' Body ALPA India Urges DGCA To Suspend Dubai, Abu Dhabi-Bound Flights Amid Middle-East Tensions - NDTV Profit
Frequently Asked Questions
What is Alpa Laboratories's current stock price?
Alpa Laboratories shares were last quoted at ₹55.71 (-2.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Alpa Laboratories?
Alpa Laboratories has a price-to-earnings (P/E) ratio of 35.69 and a price-to-book (P/B) ratio of 0.67. The industry P/E is 53.33.
What is the 52-week high and low of Alpa Laboratories?
The 52-week high of Alpa Laboratories is ₹99.75 and the 52-week low is ₹46.00.
What is the market cap of Alpa Laboratories?
The market capitalisation of Alpa Laboratories is about ₹124.64 crore.
How did Alpa Laboratories perform in its latest quarterly results?
In the latest quarter (Jun 2026), Alpa Laboratories reported sales of ₹23.93 crore (+25.2%) and net profit of ₹0.98 crore (-91.7%), compared with the same quarter last year.
Is Alpa Laboratories a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Alpa Laboratories has a 3-year ROE of 11.00%, 3-year profit growth of 6.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Alpa Laboratories?
Promoters hold about 57.19% of Alpa Laboratories.
Which sector does Alpa Laboratories belong to?
Alpa Laboratories belongs to the Pharmaceuticals & Drugs sector.